|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| C12N 15/62 | |||
| A61P 7/06 |
| (11) | Patento numeris | 2468291 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11195140.6 |
| Europos patento paraiškos padavimo data | 2007-12-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-06-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 87568206 P | 2006-12-18 | US |
| (72) |
Sherman, Matthew L., US
|
| (73) |
Acceleron Pharma, Inc.,
149 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS |
| ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS |